MRI (magnetic resonance imaging) guided breast biopsy planned:
This article was originally published in Clinica
Executive Summary
Open MRI system manufacturer Fonar is developing an image-guided biopsy technique for use in the early detection of breast cancer. The aim is to improve on the false negative rate of X-ray mammography and the false positive rate of MRI mammography. The new technique will use the Melville, New York-based company's works-in-progress, room-sized magnets, Open Sky MRI and OR-360.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.